AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Syntara Ltd

0.023

-0.002-8.00%

Volume:357.07K

Turnover:9K

Market Cap:45.12M

PE:-4.24

High:0.025

Open:0.025

Low:0.023

Close:0.025

52wk High:0.040

52wk Low:0.019

Shares:1.96B

Float Shares:1.00B

Volume Ratio:0.82

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.005

EPS(LYR):-0.005

ROE:-59.65%

ROA:-29.81%

PB:2.78

PE(LYR):-4.24

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Syntara Ltd - FY Prelim Revenues from Ordinary Activities and Other Income A$7 Mln

THOMSON REUTERS

Syntara Ltd-azalox Mds Study Advances to Final Phase 1B Cohort

THOMSON REUTERS

Syntara's Parkinson's-Linked Drug Candidate Shows Encouraging Trial Results, Says Euroz Hartleys

MT Newswires Live

Syntara Seeks Trading Halt

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/SNT.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SNT.AU\",,,,,undefined,":{"symbol":"SNT.AU","market":"AU","secType":"STK","nameCN":"Syntara Ltd","latestPrice":0.023,"timestamp":1789539120000,"preClose":0.025,"halted":0,"volume":357066,"delay":0,"changeRate":-0.08000000000000007,"nameEN":"Syntara Ltd","floatShares":1004676595,"shares":1961906275,"eps":-0.005429,"marketStatus":"Not Yet Opened","change":-0.002,"latestTime":"09-16 16:12:00 AEST","open":0.025,"high":0.025,"low":0.023,"amount":8538,"amplitude":0.08,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.005429,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.025,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.8205365548468498,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"SNT.AU","preClose":0.024,"auctionPrice":0.024,"auctionVolume":89656,"auction":3,"marketStatus":"盘后竞价","timestamp":1789106551879}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SNT.AU\",,,,,undefined,":{"symbol":"SNT.AU","floatShares":1004676595,"roa":"-29.81%","roe":"-59.65%","lyrEps":-0.005429,"volumeRatio":0.8205365548468498,"shares":1961906275,"dividePrice":0,"high":0.025,"amplitude":0.08,"preClose":0.025,"low":0.023,"week52Low":0.019,"pbRate":"2.78","psRate":"6.51","week52High":0.04,"institutionHeld":0,"latestPrice":0.023,"eps":-0.005429,"divideRate":0,"volume":357066,"delay":0,"ttmEps":-0.005429,"open":0.025,"prevYearClose":0.035,"prevWeekClose":0.025,"prevMonthClose":0.026,"prevQuarterClose":0.02,"fiveDayClose":0.024,"twentyDayClose":0.027,"sixtyDayClose":0.023},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNT.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-07-28","symbol":"SNT.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1785160800000,"reportTimeType":"","actualEps":null},{"date":"2025-05-01","symbol":"SNT.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1746057600000,"name":null,"time":"","dateTimestamp":1746021600000,"actualEps":null},{"market":"AU","date":"2024-10-29","symbol":"SNT.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1730120400000,"reportTimeType":"pre","actualEps":null},{"date":"2024-04-30","symbol":"SNT.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714435200000,"name":null,"time":"","dateTimestamp":1714399200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNT.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662203577","title":"Syntara Ltd - FY Prelim Revenues from Ordinary Activities and Other Income A$7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203577?lang=en_us&edition=fundamental","pubTime":"2026-08-27 12:50","pubTimestamp":1787806254,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44N19A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","SNT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652268086","title":"Syntara Ltd-azalox Mds Study Advances to Final Phase 1B Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2652268086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652268086?lang=en_us&edition=fundamental","pubTime":"2026-07-20 08:01","pubTimestamp":1784505714,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUE2TTVLT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649973672","title":"Syntara's Parkinson's-Linked Drug Candidate Shows Encouraging Trial Results, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2649973672","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649973672?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:08","pubTimestamp":1783379325,"startTime":"0","endTime":"0","summary":"Syntara's  positive headline results from a Phase 2 trial of its experimental drug for isolated REM Sleep Behaviour Disorder  indicate that the trial objectives were met, Euroz Hartleys said in a note on Monday.The investment firm said the encouraging results confirm that the drug candidate SNT-4728 is safe and well-tolerated.The trial also enrolled iRBD patients who are at a high risk of developing Parkinson's, making the findings more relevant to the drug's potential use in Parkinson's disease.The brokerage sees a significant potential market opportunity due to the lack of approved treatments for iRBD.Euroz Hartleys maintained a speculative buy rating on Syntara with a price target of $0.16.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SNT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648463921","title":"Syntara Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2648463921","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648463921?lang=en_us&edition=fundamental","pubTime":"2026-07-03 07:23","pubTimestamp":1783034618,"startTime":"0","endTime":"0","summary":"BRIEF-Syntara Seeks Trading HaltJuly 3 (Reuters)-Syntara LtdSNT.AX:TRADING HALT PENDING PRELIMINARY RESULTS FROM IRBD PARKINSON’S DISEASE STUDY OF SNT-4728Further company coverage:SNT.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN4340Y6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SNT.AU\",params:#limit:6,delay:true,,,undefined,":[]}}